Home » Business News » 2013 » October » October 7, 2013

BioCrea to Present at 12th Annual BIO Investor Forum

October 7, 2013 - London

BioCrea /BioCrea to Present at 12th Annual BIO Investor Forum . Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

BIO Investor Forum to be held October 8-9 in San Francisco, USA

Radebeul, Germany, October 7, 2013 - BioCrea GmbH (BioCrea), the first-in-class CNS drug discovery specialists validated through pharma partnerships, announced that Dr. Tom Kronbach, CEO, will be presenting at the 12th Annual BIO Investor Forum. Hosted by the Biotechnology Industry Organization (BIO), the 12th Annual BIO Investor Forum features leading private and emerging public companies. The meeting will take place October 8-9 at the Palace Hotel in San Francisco, CA, USA.

"I highly value the opportunities and the comprehensive network with industry leaders that the BIO Investor Forum offers", said Dr. Tom Kronbach, Chief Executive Officer of BioCrea GmbH. "As a new member of BIO, I am looking forward to participate in the conference and to introduce BioCrea as a German CNS drug development specialist."


Dr. Tom Kronbach
October 09, 2013
9:30 am PDT
The Palace Hotel, San Francisco, USA
Room: Pacific Heights

About BioCrea

BioCrea is the Radebeul-based first-in-class drug discovery specialist validated through pharma partnerships. The company boasts a provable track record in effective drug discovery driven by knowledge, flexibility and extensive experience. BioCrea's expertise is founded on the continuing discovery and optimization of selective ion channel and enzyme modulators - agents that offer significant potential for maximizing the efficacy and tolerability of new therapeutics. BioCrea was awarded Top Innovator status of the "Top 100" Most Innovative Companies in Germany, 2012 by compamedia GmbH.

About the BIO Investor Forum

The 12th Annual BIO Investor Forum is an international investor conference focused on private and emerging public biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.In addition, the BIO Investor Forum draws business development executives from leading global pharmaceutical and established biotechnology companies.


Dr. Tom Kronbach
CEO, BioCrea GmbH
Tel.: +49 351 / 4043 3332
Fax: +49 351 / 4043 3216

Press Release PDF

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: BioCrea via Thomson Reuters ONE



Comment on this story